Skip to content

Leronlimab

Leronlimab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target C-C chemokine receptor type 5.
Trade Name
Common Name Leronlimab
Indication
Drug Class Monoclonal antibodies: immunomodulating
Leronlimab
Get full access now